Hematopoietic stem cell transplant
Conditions
Interventions
This cross-sectional study will be conducted at the Special Immunobiological Reference Center (CRIE) of the Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz), in collaboration wit
Sponsors
Instituto Nacional de Infectologia - INI / Fiocruz
Instituto Nacional de Infectologia - INI / Fiocruz
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals of both genders; aged 18 and older; post hematopoietic stem cell transplant at any time post-transplant and having received yellow fever vaccination pre-transplant; ability to comprehend and sign the informed consent form freely and with understanding
Exclusion criteria
Exclusion criteria: Vaccination against yellow fever after stem cell transplant; not having received yellow fever vaccination before the transplant; any condition that, in the Investigator's or their designees' assessment, may hinder the provision of informed consent, make participation in the study unsafe, impair data interpretation; or in any way interfere with the achievement of the study's objectives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the Immune response to yellow fever vaccination in individuals undergoing hematopoietic stem cell transplantation (TCTH) will be present | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactLuciana Pedro
Instituto Nacional de Infectologia - INI / Fiocruz
Outcome results
None listed